Awarded

Część 2 – Lek stosowany w programie leczenia chorych z nerwiakowłokniakami splotowatymi w przebiegu neurofibromatozy typu 1 (NT1)

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
Contract value
PLN 1,266,222
Published
21 Nov 2025
Awarded
20 Nov 2025
Contract start
1 Jan 2026
Contract end
31 Dec 2026stated

More awards from this buyer